$HRGN·4/A

Biostage, Inc. · May 20, 12:08 PM ET

Biostage, Inc. 4/A

4/A · Biostage, Inc. · Filed May 20, 2016

Insider Transaction Report

Form 4/AAmended
Period: 2016-05-19
Transactions
  • Purchase

    Common Stock

    2016-05-19$1.36/sh+18,000$24,40118,000 total
Footnotes (2)
  • [F1]This report is being filed to amend the footnote description contained in a Form 4 pertaining to the above transaction, filed on 5/20/2016. The description contained in that Form 4 filing incorrectly described the transaction as a sale instead of a purchase of shares.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.315 to $1.38, inclusive. The reporting person undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.

Documents

1 file
  • 4
    v440589_4a.xml

    FORM 4/A